Literature DB >> 1883204

The biochemistry of AIDS.

Y N Vaishnav1, F Wong-Staal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1883204     DOI： 10.1146/annurev.bi.60.070191.003045

Source DB:  PubMed          Journal:  Annu Rev Biochem        ISSN： 0066-4154            Impact factor:   23.643


× No keyword cloud information.
  92 in total

1.  The frameshift signal of HIV-1 involves a potential intramolecular triplex RNA structure.

Authors:  Jonathan D Dinman; Sara Richter; Ewan P Plant; Ronald C Taylor; Amy B Hammell; Tariq M Rana
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

2.  Chromatin disruption and histone acetylation in regulation of the human immunodeficiency virus type 1 long terminal repeat by thyroid hormone receptor.

Authors:  Shao-Chung Victor Hsia; Yun-Bo Shi
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

3.  TCR-independent CD28-mediated gene expression in peripheral blood lymphocytes from donors chronically infected with HIV-1.

Authors:  J G Wong; M D Smithgall; O K Haffar
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

4.  Origins of genes: "big bang" or continuous creation?

Authors:  P K Keese; A Gibbs
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

5.  Human immunodeficiency virus type 1 Rev activation can be achieved without Rev-responsive element RNA if Rev is directed to the target as a Rev/MS2 fusion protein which tethers the MS2 operator RNA.

Authors:  S Venkatesan; S M Gerstberger; H Park; S M Holland; Y Nam
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

6.  A specific sequence with a bulged guanosine residue(s) in a stem-bulge-stem structure of Rev-responsive element RNA is required for trans activation by human immunodeficiency virus type 1 Rev.

Authors:  S M Holland; M Chavez; S Gerstberger; S Venkatesan
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

Review 7.  The AIDS virus. What we know and what we can do about it.

Authors:  F Wong-Staal
Journal:  West J Med       Date:  1991-11

Review 8.  Antiviral therapy in human immunodeficiency virus infections. Current status (Part II).

Authors:  E Sandström; B Oberg
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

9.  Molecular cloning and characterization of a cellular protein that interacts with the human immunodeficiency virus type 1 Tat transactivator and encodes a strong transcriptional activation domain.

Authors:  L Yu; Z Zhang; P M Loewenstein; K Desai; Q Tang; D Mao; J S Symington; M Green
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

10.  Fibronectin modulates the effects of HIV-1 Tat on the growth of murine Kaposi's sarcoma-like cells through the down-regulation of tyrosine phosphorylation.

Authors:  Z Wu; U Cavallaro; P C Marchisio; M R Soria; J A Maier
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.